Yhb Investment Advisors, Inc. Baxter International Inc Transaction History

Yhb Investment Advisors, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 26, 2024	BUY	$37.88 - $43.77 $15,152 - $17,508	400 New	400 $17,000
Q4 2019 Jan 27, 2020	SELL	$76.7 - $88.45 $213,456 - $246,156	-2,783 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$81.4 - $89.78 $4,070 - $4,489	-50 Reduced 1.76%	2,783 $243,000
Q2 2019 Jul 15, 2019	SELL	$73.44 - $82.41 $77,112 - $86,530	-1,050 Reduced 27.04%	2,833 $232,000
Q1 2019 Apr 29, 2019	SELL	$64.48 - $81.31 $19,344 - $24,393	-300 Reduced 7.17%	3,883 $316,000
Q4 2018 Jan 11, 2019	SELL	$61.45 - $77.8 $156,697 - $198,390	-2,550 Reduced 37.87%	4,183 $275,000
Q2 2018 Jul 09, 2018	SELL	$63.43 - $75.41 $3,171 - $3,770	-50 Reduced 0.74%	6,733 $497,000
Q1 2018 Apr 16, 2018	SELL	$62.56 - $72.26 $3,128 - $3,613	-50 Reduced 0.73%	6,783 $441,000
Q4 2017 Jan 16, 2018	BUY	$61.45 - $66.05 $3,072 - $3,302	50 Added 0.74%	6,833 $442,000
Q3 2017 Nov 06, 2017	BUY	$59.5 - $64.61 $403,588 - $438,249	6,783	6,783 $426,000

996

449M

1.97M

3.04M

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $18.2B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

Get notified when there are updates to the investment portfolio of Yhb Investment Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Yhb Investment Advisors, Inc. with notifications on news.